2011
DOI: 10.1136/gut.2010.220087
|View full text |Cite
|
Sign up to set email alerts
|

Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis

Abstract: Background & Aims Recently there has been emerging epidemiological data to suggest Helicobacter pylori (H. pylori) may protect against certain chronic inflammatory diseases such as inflammatory bowel disease (IBD). However, the mechanism for the observed inverse association between H. pylori and IBD has not been described. Methods The frequency of immunoregulatory (IRS) to immunostimulatory (ISS) sequences within the genome of various bacteria was calculated using MacVector software. The induction of type I … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
96
2
1

Year Published

2011
2011
2024
2024

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 96 publications
(103 citation statements)
references
References 48 publications
4
96
2
1
Order By: Relevance
“…H. pylori DNA suppresses type 1 interferon and IL-12 production from mouse bone marrow-derived dendritic cells, possibly owing to its high immunoregulatory sequence to immunostimulatory sequence ratio. This may explain why the systemic levels of type 1 interferon were found to be lower in H. pyloricolonized patients than noncolonized controls [17]. We also showed that the administration of isolated H. pylori DNA significantly ameliorated the severity of experimental colitis in mice.…”
Section: Mechanismssupporting
confidence: 56%
See 1 more Smart Citation
“…H. pylori DNA suppresses type 1 interferon and IL-12 production from mouse bone marrow-derived dendritic cells, possibly owing to its high immunoregulatory sequence to immunostimulatory sequence ratio. This may explain why the systemic levels of type 1 interferon were found to be lower in H. pyloricolonized patients than noncolonized controls [17]. We also showed that the administration of isolated H. pylori DNA significantly ameliorated the severity of experimental colitis in mice.…”
Section: Mechanismssupporting
confidence: 56%
“…In subsequent studies we further demonstrated that H. pylori DNA decreases proinflammatory cytokine production by dendritic cells and attenuates dextran sodium sulfate-induced colitis in mice. We showed that H. pylori DNA, which has been found in the colon and stool of infected patients [15,16], has immunoregulatory properties [17]. H. pylori DNA suppresses type 1 interferon and IL-12 production from mouse bone marrow-derived dendritic cells, possibly owing to its high immunoregulatory sequence to immunostimulatory sequence ratio.…”
Section: Mechanismsmentioning
confidence: 99%
“…Several recent studies have independently documented the distinct ability of H. pylori to reprogram DCs toward a tolerogenic phenotype in vitro and in vivo, ensuring persistence of the bacteria and cross-protecting against chronic inflammatory and autoimmune diseases (11,12,23,24). H. pylori-experienced DCs appear to preferentially prime Treg over Th1 or Th17 responses and fail to produce proinflammatory cytokines (11,12,24).…”
Section: Discussionmentioning
confidence: 99%
“…In our original work, we highlighted the elevated IRS to ISS ratios across various H. pylori strains, close to 30-fold in most instances. 2 In this addendum, we aimed to determine the presence of any dominant known IRS sequence 5 in H. pylori and whether it is conserved across all H. pylori strains measured. We found that the specific IRS sequence TTTAG-GGG occurs greater than 20 times in each H. pylori genome and this sequence dominates all other known IRS sequences (Fig.…”
Section: Introductionmentioning
confidence: 99%
“…2 We turned our attention toward the HP DNA, given documentation of its presence in the stool and colon of infected patients. 3,4 Therefore, the DNA could offer a physical connection between a bacterium that strictly colonizes the stomach with an inflammatory condition that more commonly affects the small bowel and colon.…”
Section: Introductionmentioning
confidence: 99%